Kara M. Kelly

Women & Children's Hospital of Buffalo — United States

Medicine · Health Sciences

50h-index9.2kcitations393works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(182), Childhood Cancer Survivors' Quality of Life(143), Acute Lymphoblastic Leukemia research(135), Lung Cancer Treatments and Mutations(45), CNS Lymphoma Diagnosis and Treatment(45)

Publications391 total

Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131
Klinische Pädiatrie·2025
Survival By Race/Ethnicity in Children and Adolescents/Young Adults with Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials
Klinische Pädiatrie·2025
AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy to Immuno-oncology for Children & Adults with Newly Diagnosed Stage I and II Hodgkin Lymphoma
Klinische Pädiatrie·2025
Multi-modality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma
Klinische Pädiatrie·2025
Scientific update from the Global NLPHL One Working Group (GLOW)
Klinische Pädiatrie·2025
Predicted Breast Cancer Risk after Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Analysis of a Multi-Institutional Children’s Oncology Group Trial
Klinische Pädiatrie·2025
Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma
International Journal of Radiation Oncology*Biology*Physics·2025
Hodgkin Lymphoma involving the CNS: An AHOD1331, PHL-C1 and PHL-C2 Report from the Children's Oncology Group and the European Network for Pediatric Hodgkin Lymphoma
Klinische Pädiatrie·2025
Tumor-Specific Immune Responses and Biomarkers in pediatric High-Risk Hodgkin Lymphoma Patients
Klinische Pädiatrie·2025
Prognostic value of 18F-FDG PET/CT volumetric parameters in childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL): a systematic review from the international SEARCH group (Staging, Evaluation and Response Criteria Harmonization)
Klinische Pädiatrie·2025
Supplementary Figure 1 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Changes in body composition during early phases of treatment and subsequent risk of relapse in childhood Hodgkin lymphoma
Blood·2025Open Access
The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)
Blood·2025Open Access
Supplementary Figure 2 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study
Blood·2025· 1 citedOpen Access
Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.
Blood·2025Open Access
Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001
Blood·2025Open Access
Supplementary Table 1 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Age at diagnosis drives molecular pathology and prognosis in diffuse large B-cell lymphoma
Blood·2025
Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826
Blood·2025Open Access
page 1 of 20Next →

Frequent Co-authors

Lewis B. Silverman(15), Kristen E. Stevenson(13), Stephen E. Sallan(13), Bruno Michon(13), Peter D. Cole(13), Donna Neuberg(12), Luis A. Clavell(12), Caroline Laverdière(12), Barbara L. Asselin(11), Uma H. Athale(11), Marshall A. Schorin(11), Elena J. Ladas(10), Lynda M. Vrooman(8), Jennifer Welch(7), Cindy L. Schwartz(7), Jeffrey G. Supko(6), Kathleen M. McCarten(6), Harvey J. Cohen(5), Jane E. O’Brien(5), Marian H. Harris(5)